> 0 1 0 1 O
21 2 4 2 4 B-lower_bound
years 5 10 5 10 I-lower_bound
of 11 13 11 13 O
age 14 17 14 17 B-age

Body 0 4 18 22 B-bmi
mass 5 9 23 27 I-bmi
index 10 15 28 33 I-bmi
â‰¤ 16 17 34 35 O
30 18 20 36 38 B-upper_bound
kg 21 23 39 41 I-upper_bound
/ 23 24 41 42 I-upper_bound
m2 24 26 42 44 I-upper_bound

Conservative 0 12 45 57 B-treatment
therapy 13 20 58 65 I-treatment
is 21 23 66 68 O
defined 24 31 69 76 O
as 32 34 77 79 O
systemic 35 43 80 88 B-treatment
pain 44 48 89 93 I-treatment
medications 49 60 94 105 I-treatment
and 61 64 106 109 O
anti 65 69 110 114 B-treatment
- 69 70 114 115 I-treatment
inflammatory 70 82 115 127 I-treatment
medications 83 94 128 139 I-treatment
, 94 95 139 140 O
as 96 98 141 143 O
well 99 103 144 148 O
as 104 106 149 151 O
physical 107 115 152 160 B-treatment
therapy 116 123 161 168 I-treatment
, 123 124 168 169 O
such 125 129 170 174 O
as 130 132 175 177 O
massage 133 140 178 185 B-treatment
, 140 141 185 186 O
heating 142 149 187 194 B-treatment
, 149 150 194 195 O
hydrotherapy 151 163 196 208 B-treatment
, 163 164 208 209 O
and 165 168 210 213 O
strengthening 169 182 214 227 B-treatment
exercises 183 192 228 237 I-treatment

Individuals 0 11 238 249 O
who 12 15 250 253 O
are 16 19 254 257 O
not 20 23 258 261 O
able 24 28 262 266 O
or 29 31 267 269 O
willing 32 39 270 277 O
to 40 42 278 280 O
tolerate 43 51 281 289 O
the 52 55 290 293 O
required 56 64 294 302 O
prolonged 65 74 303 312 O
stationary 75 85 313 323 O
position 86 94 324 332 O
during 95 101 333 339 O
treatment 102 111 340 349 B-treatment
( 112 113 350 351 O
can 113 116 351 354 O
be 117 119 355 357 O
up 120 122 358 360 O
to 123 125 361 363 O
5 126 127 364 365 B-upper_bound
hrs 128 131 366 369 I-upper_bound
of 132 134 370 372 O
total 135 140 373 378 O
table 141 146 379 384 O
time 147 151 385 389 O
) 151 152 389 390 O

Men 0 3 391 394 B-gender

Patients 0 8 395 403 O
must 9 13 404 408 O
have 14 18 409 413 O
an 19 21 414 416 O
analgesic 22 31 417 426 O
response 32 40 427 435 O
to 41 43 436 438 O
either 44 50 439 445 O
prior 51 56 446 451 B-treatment
local 57 62 452 457 I-treatment
anesthetic 63 73 458 468 I-treatment
injection 74 83 469 478 I-treatment
to 84 86 479 481 O
the 87 90 482 485 O
facet 91 96 486 491 O
joint 97 102 492 497 O
or 103 105 498 500 O
to 106 108 501 503 O
radiofrequency 109 123 504 518 B-treatment
ablation 124 132 519 527 I-treatment
of 133 135 528 530 O
the 136 139 531 534 O
facet 140 145 535 540 O
joint 146 151 541 546 O
, 151 152 546 547 O
with 153 157 548 552 O
relapse 158 165 553 560 O
of 166 168 561 563 O
pain 169 173 564 568 O

Patients 0 8 569 577 O
must 9 13 578 582 O
have 14 18 583 587 O
chronic 19 26 588 595 O
LBP 27 30 596 599 B-chronic_disease
attributed 31 41 600 610 O
to 42 44 611 613 O
facet 45 50 614 619 O
joints 51 57 620 626 O
as 58 60 627 629 O
demonstrated 61 73 630 642 O
by 74 76 643 645 O
MRI 77 80 646 649 B-treatment
consistent 81 91 650 660 O
with 92 96 661 665 O
at 97 99 666 668 O
least 100 105 669 674 O
grade 106 111 675 680 B-lower_bound
2 112 113 681 682 I-lower_bound
facet 114 119 683 688 B-chronic_disease
joint 120 125 689 694 I-chronic_disease
arthritis 126 135 695 704 I-chronic_disease
, 135 136 704 705 O
with 137 141 706 710 O
corresponding 142 155 711 724 O
abnormal 156 164 725 733 O
activity 165 173 734 742 O
at 174 176 743 745 O
the 177 180 746 749 O
facet 181 186 750 755 O
joint 187 192 756 761 O
on 193 195 762 764 O
18F 196 199 765 768 O
- 199 200 768 769 O
sodium 200 206 769 775 O
fluoride 207 215 776 784 O
PET 216 219 785 788 O
- 219 220 788 789 O
CT 220 222 789 791 O

Patients 0 8 792 800 O
who 9 12 801 804 O
are 13 16 805 808 O
part 17 21 809 813 O
of 22 24 814 816 O
another 25 32 817 824 B-treatment
trial 33 38 825 830 I-treatment
testing 39 46 831 838 O
other 47 52 839 844 O
Investigational 53 68 845 860 B-treatment
Agents 69 75 861 867 I-treatment

Patients 0 8 868 876 O
who 9 12 877 880 O
are 13 16 881 884 O
taking 17 23 885 891 O
anti 24 28 892 896 B-treatment
- 28 29 896 897 I-treatment
thrombotic 29 39 897 907 I-treatment
medication 40 50 908 918 I-treatment

Patients 0 8 919 927 O
with 9 13 928 932 O
Numerical 14 23 933 942 O
Rating 24 30 943 949 O
Scale 31 36 950 955 O
worst 37 42 956 961 O
lumbar 43 49 962 968 B-clinical_variable
back 50 54 969 973 I-clinical_variable
pain 55 59 974 978 I-clinical_variable
score 60 65 979 984 I-clinical_variable
of 66 68 985 987 O
at 69 71 988 990 O
least 72 77 991 996 O
4 78 79 997 998 B-lower_bound
out 80 83 999 1002 O
of 84 86 1003 1005 O
10 87 89 1006 1008 B-upper_bound
over 90 94 1009 1013 O
the 95 98 1014 1017 O
24 99 101 1018 1020 B-upper_bound
hours 102 107 1021 1026 I-upper_bound
preceding 108 117 1027 1036 I-upper_bound
the 118 121 1037 1040 O
time 122 126 1041 1045 O
of 127 129 1046 1048 O
rating 130 136 1049 1055 O

Patients 0 8 1056 1064 O
with 9 13 1065 1069 O
acute 14 19 1070 1075 B-chronic_disease
medical 20 27 1076 1083 I-chronic_disease
condition 28 37 1084 1093 I-chronic_disease
( 38 39 1094 1095 O
e.g. 39 43 1095 1099 O
pneumonia 44 53 1100 1109 B-chronic_disease
, 53 54 1109 1110 O
sepsis 55 61 1111 1117 B-chronic_disease
) 61 62 1117 1118 O
that 63 67 1119 1123 O
is 68 70 1124 1126 O
expected 71 79 1127 1135 O
to 80 82 1136 1138 O
hinder 83 89 1139 1145 O
them 90 94 1146 1150 O
from 95 99 1151 1155 O
completing 100 110 1156 1166 O
this 111 115 1167 1171 O
study 116 121 1172 1177 O

Patients 0 8 1178 1186 O
with 9 13 1187 1191 O
at 14 16 1192 1194 O
least 17 22 1195 1200 O
6 23 24 1201 1202 B-lower_bound
months 25 31 1203 1209 I-lower_bound
of 32 34 1210 1212 O
chronic 35 42 1213 1220 B-chronic_disease
lower 43 48 1221 1226 I-chronic_disease
back 49 53 1227 1231 I-chronic_disease
pain 54 58 1232 1236 I-chronic_disease
( 59 60 1237 1238 I-chronic_disease
LBP 60 63 1238 1241 I-chronic_disease
) 63 64 1241 1242 I-chronic_disease
localized 65 74 1243 1252 O
to 75 77 1253 1255 O
the 78 81 1256 1259 O
midline 82 89 1260 1267 O
or 90 92 1268 1270 O
axial 93 98 1271 1276 O
low 99 102 1277 1280 O
back 103 107 1281 1285 O
, 107 108 1285 1286 O
with 109 113 1287 1291 O
symptoms 114 122 1292 1300 O
attributed 123 133 1301 1311 O
to 134 136 1312 1314 O
the 137 140 1315 1318 O
facet 141 146 1319 1324 O
joints 147 153 1325 1331 O
on 154 156 1332 1334 O
physical 157 165 1335 1343 O
examination 166 177 1344 1355 O
that 178 182 1356 1360 O
have 183 187 1361 1365 O
persisted 188 197 1366 1375 O
despite 198 205 1376 1383 O
conservative 206 218 1384 1396 B-treatment
therapy 219 226 1397 1404 I-treatment

Patients 0 8 1405 1413 O
with 9 13 1414 1418 O
contraindication 14 30 1419 1435 O
for 31 34 1436 1439 O
MR 35 37 1440 1442 B-treatment
imaging 38 45 1443 1450 I-treatment
such 46 50 1451 1455 O
as 51 53 1456 1458 O
implanted 54 63 1459 1468 O
metallic 64 72 1469 1477 O
devices 73 80 1478 1485 O
that 81 85 1486 1490 O
are 86 89 1491 1494 O
not 90 93 1495 1498 O
MRI 94 97 1499 1502 B-treatment
- 97 98 1502 1503 O
safe 98 102 1503 1507 O
, 102 103 1507 1508 O
size 104 108 1509 1513 O
limitations 109 120 1514 1525 O
, 120 121 1525 1526 O
claustrophobia 122 136 1527 1541 B-chronic_disease
. 136 137 1541 1542 O
etc 138 141 1543 1546 O

Patients 0 8 1547 1555 O
with 9 13 1556 1560 O
evidence 14 22 1561 1569 O
of 23 25 1570 1572 O
lumbosacral 26 37 1573 1584 B-chronic_disease
radiculopathy 38 51 1585 1598 I-chronic_disease
on 52 54 1599 1601 O
MRI 55 58 1602 1605 B-treatment
or 59 61 1606 1608 O
physical 62 70 1609 1617 O
exam 71 75 1618 1622 O
findings 76 84 1623 1631 O
, 84 85 1631 1632 O
including 86 95 1633 1642 O
radicular 96 105 1643 1652 B-chronic_disease
leg 106 109 1653 1656 I-chronic_disease
pain 110 114 1657 1661 I-chronic_disease
, 114 115 1661 1662 O
or 116 118 1663 1665 O
any 119 122 1666 1669 O
neurologic 123 133 1670 1680 B-chronic_disease
deficit 134 141 1681 1688 I-chronic_disease
at 142 144 1689 1691 O
or 145 147 1692 1694 O
below 148 153 1695 1700 O
the 154 157 1701 1704 O
segmental 158 167 1705 1714 O
level 168 173 1715 1720 O
of 174 176 1721 1723 O
the 177 180 1724 1727 O
highest 181 188 1728 1735 O
facet 189 194 1736 1741 O
to 195 197 1742 1744 O
be 198 200 1745 1747 O
treated 201 208 1748 1755 O
, 208 209 1755 1756 O
including 210 219 1757 1766 O
subjects 220 228 1767 1775 O
with 229 233 1776 1780 O
impaired 234 242 1781 1789 O
sphincter 243 252 1790 1799 O
control 253 260 1800 1807 O

Patients 0 8 1808 1816 O
with 9 13 1817 1821 O
gross 14 19 1822 1827 B-chronic_disease
spinal 20 26 1828 1834 I-chronic_disease
instability 27 38 1835 1846 I-chronic_disease
on 39 41 1847 1849 O
imaging 42 49 1850 1857 O

Patients 0 8 1858 1866 O
with 9 13 1867 1871 O
inflammatory 14 26 1872 1884 B-chronic_disease
arthritides 27 38 1885 1896 I-chronic_disease

Patients 0 8 1897 1905 O
with 9 13 1906 1910 O
known 14 19 1911 1916 O
intolerance 20 31 1917 1928 O
or 32 34 1929 1931 O
allergy 35 42 1932 1939 O
to 43 45 1940 1942 O
MR 46 48 1943 1945 B-allergy_name
contrast 49 57 1946 1954 I-allergy_name
agent 58 63 1955 1960 I-allergy_name
( 64 65 1961 1962 O
gadolinium 65 75 1962 1972 B-allergy_name
chelates 76 84 1973 1981 I-allergy_name
) 84 85 1981 1982 O
including 86 95 1983 1992 O
advanced 96 104 1993 2001 O
kidney 105 111 2002 2008 B-chronic_disease
disease 112 119 2009 2016 I-chronic_disease
( 120 121 2017 2018 O
GFR 121 124 2018 2021 B-clinical_variable
< 125 126 2022 2023 O
30 126 128 2023 2025 B-upper_bound
mL 129 131 2026 2028 I-upper_bound
/ 131 132 2028 2029 I-upper_bound
min/1.73 132 140 2029 2037 I-upper_bound
m2 141 143 2038 2040 I-upper_bound
) 143 144 2040 2041 O
or 145 147 2042 2044 O
on 148 150 2045 2047 O
dialysis 151 159 2048 2056 O

Patients 0 8 2057 2065 O
with 9 13 2066 2070 O
known 14 19 2071 2076 O
intolerance 20 31 2077 2088 O
or 32 34 2089 2091 O
allergy 35 42 2092 2099 O
to 43 45 2100 2102 O
medications 46 57 2103 2114 B-allergy_name
used 58 62 2115 2119 O
for 63 66 2120 2123 O
sedation 67 75 2124 2132 B-treatment
( 76 77 2133 2134 I-treatment
midazolam 77 86 2134 2143 I-treatment
) 86 87 2143 2144 I-treatment
, 87 88 2144 2145 O
analgesia 89 98 2146 2155 B-treatment
( 99 100 2156 2157 I-treatment
fentanyl 100 108 2157 2165 I-treatment
) 108 109 2165 2166 I-treatment
, 109 110 2166 2167 O
and 111 114 2168 2171 O
local 115 120 2172 2177 B-treatment
and 121 124 2178 2181 O
regional 125 133 2182 2190 B-treatment
anesthesia 134 144 2191 2201 I-treatment
( 145 146 2202 2203 O
lidocaine 146 155 2203 2212 B-treatment
, 155 156 2212 2213 O
bupivacaine 157 168 2214 2225 B-treatment
, 168 169 2225 2226 O
and 170 173 2227 2230 O
ropivacaine 174 185 2231 2242 B-treatment
) 185 186 2242 2243 O

Patients 0 8 2244 2252 O
with 9 13 2253 2257 O
severe 14 20 2258 2264 O
hematologic 21 32 2265 2276 B-chronic_disease
, 32 33 2276 2277 O
neurologic 34 44 2278 2288 B-chronic_disease
, 44 45 2288 2289 O
or 46 48 2290 2292 O
other 49 54 2293 2298 O
uncontrolled 55 67 2299 2311 O
disease 68 75 2312 2319 O
( 76 77 2320 2321 O
e.g. 77 81 2321 2325 O
platelets 82 91 2326 2335 B-clinical_variable
< 92 93 2336 2337 O
50,000 94 100 2338 2344 B-upper_bound
/ 100 101 2344 2345 I-upper_bound
microL 101 107 2345 2351 I-upper_bound
, 107 108 2351 2352 O
INR 109 112 2353 2356 B-clinical_variable
> 113 114 2357 2358 O
1.5 115 118 2359 2362 B-lower_bound
) 118 119 2362 2363 O

Patients 0 8 2364 2372 O
with 9 13 2373 2377 O
severe 14 20 2378 2384 O
hypertension 21 33 2385 2397 B-chronic_disease
( 34 35 2398 2399 O
diastolic 35 44 2399 2408 B-clinical_variable
BP 45 47 2409 2411 I-clinical_variable
> 48 49 2412 2413 O
100 50 53 2414 2417 B-lower_bound
on 54 56 2418 2420 O
medication 57 67 2421 2431 O
) 67 68 2431 2432 O

Patients 0 8 2433 2441 O
with 9 13 2442 2446 O
severe 14 20 2447 2453 O
lumbar 21 27 2454 2460 B-chronic_disease
lordosis 28 36 2461 2469 I-chronic_disease

Pregnant 0 8 2470 2478 B-pregnancy
and 9 12 2479 2482 O
nursing 13 20 2483 2490 O
patients 21 29 2491 2499 O
will 30 34 2500 2504 O
be 35 37 2505 2507 O
excluded 38 46 2508 2516 O
from 47 51 2517 2521 O
the 52 55 2522 2525 O
study 56 61 2526 2531 O
because 62 69 2532 2539 O
of 70 72 2540 2542 O
a 73 74 2543 2544 O
contraindication 75 91 2545 2561 O
to 92 94 2562 2564 O
administering 95 108 2565 2578 O
MRI 109 112 2579 2582 O
contrast 113 121 2583 2591 O
agents 122 128 2592 2598 O
to 129 131 2599 2601 O
these 132 137 2602 2607 O
patients 138 146 2608 2616 O

Severe 0 6 2617 2623 O
cerebrovascular 7 22 2624 2639 B-chronic_disease
disease 23 30 2640 2647 I-chronic_disease
( 31 32 2648 2649 O
multiple 32 40 2649 2657 B-chronic_disease
CVAs 41 45 2658 2662 I-chronic_disease
or 46 48 2663 2665 O
CVA 49 52 2666 2669 O
within 53 59 2670 2676 O
6 60 61 2677 2678 B-upper_bound
months 62 68 2679 2685 I-upper_bound
) 68 69 2685 2686 O

The 0 3 2687 2690 O
targeted 4 12 2691 2699 O
facet 13 18 2700 2705 B-clinical_variable
joint 19 24 2706 2711 I-clinical_variable
must 25 29 2712 2716 O
be 30 32 2717 2719 O
deeper 33 39 2720 2726 O
than 40 44 2727 2731 O
10 45 47 2732 2734 B-lower_bound
mm 48 50 2735 2737 I-lower_bound
from 51 55 2738 2742 O
the 56 59 2743 2746 O
skin 60 64 2747 2751 O

women 0 5 2752 2757 B-gender

